{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:15:58Z","timestamp":1788419758372,"version":"build-2803163510"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular-kidney-metabolic (CKM) syndrome encompasses metabolic abnormalities, chronic kidney disease, and cardiovascular disease. The triglyceride\u2013glucose (TyG) index reflects insulin resistance-related glucose\u2013lipid imbalance, whereas serum uric acid (SUA) reflects purine metabolism and renal urate handling. However, their independent and joint associations with advanced CKM remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional analysis of 8,939 adults from the Hakka Biobank baseline survey. Advanced CKM (stages 3\u20134) was defined according to the American Heart Association framework. Multivariable logistic regression examined associations of TyG and SUA with advanced CKM. Restricted cubic splines assessed nonlinearity, and joint associations used the same-dataset ROC-derived TyG threshold of 8.89 and sex-specific hyperuricemia (HUA) thresholds. Sensitivity and subgroup analyses assessed robustness and heterogeneity, while AUC and continuous net reclassification improvement (NRI) evaluated in-sample model performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 8,939 participants, 1,164 had advanced CKM. After adjustment, each 1-unit increase in TyG was associated with greater odds of advanced CKM (OR, 1.81; 95% CI, 1.64\u20132.01), as was each standard deviation increase in SUA (OR, 1.38; 95% CI, 1.28\u20131.48). TyG showed an approximately linear positive relationship, whereas SUA showed a J-shaped relationship (\n                      <jats:italic>P<\/jats:italic>\n                      for nonlinearity\u202f=\u202f0.004), which was more evident in women. Participants with both high TyG and HUA had the greatest odds (OR, 3.01; 95% CI, 2.49\u20133.64). Results remained consistent across six sensitivity analyses involving medication adjustment, exclusions for renal impairment or metabolic medication use, and menopausal-status adjustment among women. Jointly adding TyG and SUA improved in-sample discrimination (AUC, 0.816 vs. 0.797;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) and reclassification (NRI, 0.433; 95% CI, 0.372\u20130.496). The combined association was stronger in women (\n                      <jats:italic>P<\/jats:italic>\n                      for interaction\u202f=\u202f0.028).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher TyG and SUA levels, particularly their co-occurrence, were associated with prevalent advanced CKM. These biomarkers may characterize distinct but overlapping metabolic profiles relevant to CKM assessment. Their potential value for community-based evaluation requires confirmation in prospective studies with external validation; no causal or treatment implications can be inferred from these cross-sectional findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1933816","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:40:20Z","timestamp":1788417620000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Insulin resistance and uric acid-related metabolic disturbances jointly identify individuals at high risk of advanced cardiovascular-kidney-metabolic syndrome: a population-based study"],"prefix":"10.3389","volume":"13","author":[{"given":"Shengzhu","family":"Huang","sequence":"first","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Lin","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Ye","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxiang","family":"Fang","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yezhou","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Liang","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwu","family":"Ran","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuokun","family":"Wei","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhua","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Life Sciences and Medical Engineering, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibi","family":"Lan","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wen","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[{"name":"Bobai County People's Hospital","place":["Yulin, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengnan","family":"Mo","sequence":"additional","affiliation":[{"name":"Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circa"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio-renal-metabolic connection: a review of the evidence","volume":"22","author":"Marassi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/dom.14829","article-title":"Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan","volume":"24","author":"Kadowaki","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2337\/dc11-2339","article-title":"Defining insulin resistance from hyperinsulinemic-euglycemic clamps","volume":"35","author":"Tam","year":"2012","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.2337\/db14-0116","article-title":"Homeostastic model assessment and insulin sensitivity\/resistance","volume":"63","author":"Radziuk","year":"2014","journal-title":"Diabetes"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-021-01936-3","article-title":"Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study","volume":"19","author":"Penno","year":"2021","journal-title":"BMC Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-025-02576-0","article-title":"Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.pcd.2020.09.001","article-title":"Triglyceride-glucose index predicts independently type 2 diabetes mellitus risk: a systematic review and meta-analysis of cohort studies","volume":"14","author":"da Silva","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-020-01081-w","article-title":"Quantitative assessment of coronary plaque volume change related to triglyceride glucose index: the progression of AtheRosclerotic PlAque DetermIned by computed TomoGraphic angiography IMaging (PARADIGM) registry","volume":"19","author":"Won","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.metabol.2011.04.006","article-title":"Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides \u00d7 glucose versus triglyceride\/high-density lipoprotein cholesterol","volume":"60","author":"Abbasi","year":"2011","journal-title":"Metabolism"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","article-title":"TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study","volume":"93","author":"Vasques","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"19520","DOI":"10.1038\/srep19520","article-title":"Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"713652","DOI":"10.3389\/fcvm.2021.713652","article-title":"Serum uric acid and kidney disease measures independently predict cardiovascular and total mortality: the uric acid right for heart health (URRAH) project","volume":"8","author":"Russo","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/s0272-6386(98)70067-8","article-title":"Regulation of renal urate excretion: a critical review","volume":"32","author":"Maesaka","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00011-009-0031-9","article-title":"Insulin resistance acts as an independent risk factor exacerbating high-purine diet induced renal injury and knee joint gouty lesions","volume":"58","author":"Miao","year":"2009","journal-title":"Inflamm Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/s0026-0495(98)90026-9","article-title":"The glycolytic pathway to coronary heart disease: a hypothesis","volume":"47","author":"Leyva","year":"1998","journal-title":"Metabolism"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2478\/jtim-2024-0014","article-title":"Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition)","volume":"12","author":"Xiao","year":"2024","journal-title":"J Transl Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1253470","DOI":"10.3389\/fendo.2023.1253470","article-title":"Incidence density of hyperuricemia and association between metabolism-related predisposing risk factors and serum urate in Chinese adults: a cohort study","volume":"14","author":"Liang","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/0962280214558972","article-title":"Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models","volume":"26","author":"Austin","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4239\/wjd.v14.i4.352","article-title":"Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease","volume":"14","author":"Lin","year":"2023","journal-title":"World J Diabetes"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/biom15121745","article-title":"Insulin resistance at the crossroads of metabolic inflammation, cardiovascular disease, organ failure and cancer","volume":"15","author":"Lonardo","year":"2025","journal-title":"Biomolecules"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-022-01606-5","article-title":"Association between the triglyceride-glucose index and severity of coronary artery disease","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"102195","DOI":"10.1016\/j.redox.2021.102195","article-title":"Xanthine oxidoreductase: a leading actor in cardiovascular disease drama","volume":"48","author":"Polito","year":"2021","journal-title":"Redox Biol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41440-024-02031-9","article-title":"Current updates and future perspectives in uric acid research, 2024","volume":"48","author":"Kuwabara","year":"2024","journal-title":"Hypertens Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12964-024-01965-4","article-title":"Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"23","author":"Xu","year":"2025","journal-title":"Cell Commun Signal"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2459\/JCM.0000000000000347","article-title":"Hyperuricemia as an independent risk factor for major cardiovascular events: a 10-year cohort study from southern Italy","volume":"18","author":"Capuano","year":"2017","journal-title":"J Cardiovasc Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e052031","DOI":"10.1136\/bmjopen-2021-052031","article-title":"Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study","volume":"12","author":"Zhang","year":"2022","journal-title":"BMJ Open"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"F625","DOI":"10.1152\/ajprenal.00140.2005","article-title":"A causal role for uric acid in fructose-induced metabolic syndrome","volume":"290","author":"Nakagawa","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"641513","DOI":"10.3389\/fcvm.2021.641513","article-title":"Serum uric acid revealed a U-shaped relationship with all-cause mortality and cardiovascular mortality in high atherosclerosis risk patients: the ASSURE study","volume":"8","author":"Cang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/HYPERTENSIONAHA.117.09508","article-title":"Temporal relationship between hyperuricemia and insulin resistance and its impact on future risk of hypertension","volume":"70","author":"Han","year":"2017","journal-title":"Hypertension"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00296-015-3242-0","article-title":"Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients","volume":"35","author":"Perez-Ruiz","year":"2015","journal-title":"Rheumatol Int"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.4093\/dmj.2020.0262","article-title":"Management of cardiovascular risk in perimenopausal women with diabetes","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab J"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/ckj\/sfac030","article-title":"Sex differences in chronic kidney disease prevalence in asia: a systematic review and meta-analysis","volume":"15","author":"Hockham","year":"2022","journal-title":"Clin Kidney J"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1097\/GME.0000000000002035","article-title":"Serum uric acid levels and the risk of diabetes mellitus in premenopausal and postmenopausal women: the Suita study","volume":"29","author":"Li","year":"2022","journal-title":"Menopause"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s11886-023-01969-5","article-title":"Body fat distribution, diabetes mellitus, and cardiovascular disease: an update","volume":"25","author":"Kang","year":"2023","journal-title":"Curr Cardiol Rep"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1933816\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:40:21Z","timestamp":1788417621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1933816\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":38,"alternative-id":["10.3389\/fnut.2026.1933816"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1933816","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1933816"}}